Federal contract award
75N95022F00001
REGULATORY SUPPORT FOR LEAD GENE THERAPY CANDIDATES AS A TREATMENT FOR ORGANIC ACIDEMIAS, PROPIONIC ACIDEMIA (PA) AND METHYLMALONIC ACIDEMIA TYPE B (MMAB)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541690 — Other Scientific and Technical Consulting Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75N95022D00014 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $178.9K |
| Current contract value | $178.9K |
| Potential contract value / ceiling | $1.2M |
| Start date | Sep 22, 2022 |
| Current end date | Sep 21, 2025 |
| Potential end date | Sep 21, 2025 |
| Latest award activity | May 6, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 6, 2026 | P00003 | $-156 | FY26 UDO INITIATIVE; REGULATORY SUPPORT FOR LEAD GENE THERAPY CANDIDATES AS A TREATMENT FOR ORGANIC ACIDEMIAS, PROPIONIC ACIDEMIA (PA) AND METHYLMALONIC ACIDEMIA TYPE B (MMAB) |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.